Cappell, D. F. In Muir’s Textbook of Pathology, seventh ed. Edward Arnold Ltd., London, 1958.
Grines, C. L., Watkins, M. W., Helmer, G. et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation, 105:1291–7, 2002.
Hughes, G. C., Biswas, S. S, Yin, B. et al. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogen-esis and arteriogenesis in chronically ischemic myocardium. J. Am. Coll. Cardiol., 39:1220–8, 2002.
Isner, J. M., Pieczek, A., Schainfeld, R. et al. Clinical evidence of angiogenesis after arterial gene transfer of ph VEGF 165 in patients with ischaemic limb. Lancet, 348:370–374, 1996.
Kim, M. C., Kini, A., and Sharma, S. K. Refractory angina pectoris. Mechanisms and therapeutic options. J. Am. Coll. Cardiol., 39: 933–34, 2002.
Losordo, D. W., and Isner, J. M. Vascular endothelial growth factor-induced angiogenesis: Crouching tiger or hidden dragon? J. Am. Coll. Cardiol., 37:2131–55, 2001.
Seppo la¨-Herttuala, S., Markkanen, and J. E., Rissanen, T. T. Gene therapy for ischemic cardiovascular diseases: Some lessons learned from the first clinical trials, Trends in Cardiovascular Med., 14:(8)295–300, 2004.